Compare with Novo Nordisk A/S 1.6325% 11-JUN-2041

Credit ratings

Sign up to see this bond's credit risk

Compare credit ratings from major agencies side by side and check the overall risk level.

Key terms

Bond info

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Classification

Profile

Sign up to see advanced bond data

Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

Novo Nordisk A/S 1.6325% 11-JUN-2041